Edition:
United States

United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

126.20USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$126.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
205,682
52-wk High
$169.58
52-wk Low
$112.15

Select another date:

Tue, Nov 14 2017

BRIEF-STEADYMED RECEIVES FAVORABLE RULING FROM U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT

* ‍COURT OF APPEALS AFFIRMED A MARCH 31 RULING BY PATENT TRIAL & APPEAL BOARD INVALIDATING U.S. PATENT NO 8,497,393 OWNED BY UNITED THERAPEUTICS​

BRIEF-United Therapeutics Corp reports third quarter 2017 financial results

* United Therapeutics Corporation reports third quarter 2017 financial results

BRIEF-United Therapeutics announces FDA approval of third generation nebulizer for the Tyvaso inhalation system

* United Therapeutics announces FDA approval of third generation nebulizer for the Tyvaso inhalation system

BRIEF-United Therapeutics Corp reports Q2 EPS non-GAAP $4.37

* United Therapeutics Corporation reports second quarter 2017 financial results

BRIEF-United Therapeutics enters into agreement with Citibank relating to share repurchase program

* United Therapeutics Corp - on May 31, 2017, co entered into agreement with Citibank, N.A. relating to a collared accelerated share repurchase program

Select another date: